Atara Biotherapeutics (ATRA) EBIT (QoQ) (2013 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBIT (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Atara Biotherapeutics | 148.53 Mn | 131.97 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.10% |
| Mar 31, 2026 | -31.45% |
| Dec 31, 2025 | 28.29% |
| Sep 30, 2025 | -211.79% |
| Jun 30, 2025 | -91.76% |
| Mar 31, 2025 | 417.97% |
| Dec 31, 2024 | 43.91% |
| Sep 30, 2024 | -19.34% |
| Jun 30, 2024 | 41.66% |
| Mar 31, 2024 | 47.89% |
| Dec 31, 2023 | 13.86% |
| Sep 30, 2023 | 2.52% |
| Jun 30, 2023 | 4.80% |
| Mar 31, 2023 | 0.69% |
| Dec 31, 2022 | 10.73% |
| Sep 30, 2022 | -163.36% |
| Jun 30, 2022 | 63.58% |
| Mar 31, 2022 | 5.55% |
| Dec 31, 2021 | -10.13% |
| Sep 30, 2021 | -0.96% |